Abstract
Wendy H. Vogel, MSN, FNP, AOCNP®, of Wellmont Cancer Institute discusses results from a study in hormone receptor–positive metastatic breast cancer (MONALEESA-7), two studies in the metastatic HER2-positive setting (SOPHIA and NALA), as well as a new analysis of the TAILORx trial and a study on the effects of a low-fat diet on incidence and outcomes from the ASCO Annual Meeting, reported by The ASCO Post.
